Cooper Companies | COO - Selling And Administration Expenses

Stock Price
64.42
Daily Change
-0.53 -0.82%
Monthly
-9.84%
Yearly
-20.36%
Q2 Forecast
63.04

Cooper Companies reported $373.1M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Align Technology USD 441.68M 23.88M Dec/2025
AtriCure USD 78.34M 109K Dec/2025
Avanos Medical USD 78.8M 1.2M Dec/2025
Bausch Health Companies USD 801M 6M Dec/2025
Baxter International USD 761M 53M Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Cooper Companies USD 373.1M 46.1M Dec/2025
Dentsply International USD 383M 28M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Globus Medical USD 318.48M 4.88M Dec/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Inogen USD 43.77M 510K Jun/2024
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 613.3M 73.8M Mar/2026
J&J USD 6.03B 719M Mar/2026
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 114.83M 7.45M Dec/2025
Novartis USD 3.44B 132M Dec/2025
ResMed USD 278.4M 19.2M Dec/2025
STAAR Surgical USD 38.94M 20.44M Dec/2025
Steris USD 352.3M 2.6M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Utah Medical Products USD 2.61M 741K Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025